Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, and MicroRNA in disease regulation.
Health-related quality of life and symptoms in patients with previously untreated, locally advanced or metastatic non-squamous non-small cell lung cancer treated with sintilimab or placebo plus pemetrexed and platinum (ORIENT-11): A randomized, double-blind, phase 3 trial
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods
Classification of Tumor Immune Microenvironment According to Programmed Death-Ligand 1 Expression and Immune Infiltration Predicts Response to Immunotherapy Plus Chemotherapy in Advanced Patients With NSCLC
STK11/LKB1-Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy and Represents STING/Type I Interferon/CD8+ T-Cell Dysfunction in NSCLC
Epigenetic regulation of aging: implications for interventions of aging and diseases
Increased oxidative stress contributes to impaired peripheral CD56dimCD57+ NK cells from patients with systemic lupus erythematosus
A modifiable risk factors atlas of lung cancer: A Mendelian randomization study
Reporting of Immune Checkpoint Inhibitor Therapy–Associated Diabetes, 2015–2019
Gut Microbiota and Lung Cancer: A Mendelian Randomization Study
Education and lung cancer: a Mendelian randomization study
Mendelian randomization study showed no causality between metformin use and lung cancer risk